Open App
Profile

Mark Thornton.

Chief Executive Officer, VION Biosciences

Follow Mark Thornton

Mark Thornton is Chief Executive Officer of VION Biosciences, an Iron Path Capital-backed platform of life science services and products companies that includes CTL and Ansh Labs. He led VION's 2026 acquisition of Prolytix, which added regulated bioanalytical and CMC services as well as reagents and diagnostic workflow products.[1]

01Deal
01Company
01Roles
01Sources

As of 25 Sep 2026.

01

Career

Roles as the cited sources state them. Years are shown only where a source gives them.

  1. CurrentStart not stated

    VION Biosciences

    Chief Executive Officer

    [1]
02

Companies on Carrywatch

Company files linked to Mark Thornton by a stated role or the sourced profile.

03

Deal Web

Mark Thornton, 4 firms and 1 deal, and how they connect.

04

Deals they appear in

Deals on Carrywatch that name Mark Thornton, with the sentences that mention them.

VION Biosciences (Iron Path Capital) / Prolytix

Backed by Iron Path Capital.

CEO Mark Thornton said the deal deepens VION in regulated large molecule bioanalytical and CMC services plus reagents, consumables, and diagnostic workflow inputs. [01]

See deal details
05

News

Loading headlines.

06

Sources

Numbered as cited above.

  1. 01

Deals that name this person:

  1. 01